Urgo Healthcare, with a turnover of €311 million and 1,100 employees, is a key player in everyday healthcare, with flagship brands such as Urgo, Alvityl, Humer and Belloc, which have been part of French people’s lives for generations. As a leader in first aid, dietary supplements and hygiene, the company places innovation at the heart of its Wellness For All mission: a health partner for everyday well-being. With three new acquisitions in 2025, the company is reaffirming its international development ambitions.
Urgo Healthcare, a French family-owned company, has established a strong foothold in the international market, particularly in Europe.
Focus on the companies
Vista-Life Pharma is a Belgian company specialising in the marketing of dietary supplements, founded in 2009. With its range aimed primarily at adults, Vista-Life Pharma strengthens Urgo Healthcare Belgium’s position in the Belgian market, where it is already the leader in the children’s segment.
The Polish company MyBestPharm markets food supplements, nutraceuticals and cosmetics. With its expertise and know-how, the company has grown steadily since its creation in 2021. It aims to double its turnover by 2030, thanks to its catalogue of around twenty products, which have enabled it to quickly become a benchmark on the Polish market.
Nutriexperts completes acquisitions in 2025. Based in Catalonia, the company is present in 4,500 Spanish pharmacies. Its Nutralie brand has quickly become the market leader in Spain, thanks to high-end formulas such as Glucosamine Complex. If the name of this brand sounds familiar, that’s normal, as it is also expanding into the French and Italian markets.
A word from the chairman
Briac Le Lous, Chairman of Urgo Healthcare, said: ‘2025 is a historic year for our group: three acquisitions in less than twelve months! We are thus strengthening our presence in Europe to provide our customers with ever more innovative and high-quality solutions in the field of food supplements.’